BrainsWay Reports Strong Q1 2026 Results: Revenue Up 35%, Net Income Over 100%, Reaffirms Full-Year Guidance
BWAY has more than doubled off its 52-week low of $4.305.
Summary
BrainsWay reported strong Q1 2026 financial results with significant revenue and net income growth, alongside positive operational highlights and reaffirmed full-year guidance.
Key Events · Earnings and Guidance · BWAY
-
Strong Q1 2026 Financial Performance
Revenue grew approximately 35% year-over-year to $15.5 million, and net income increased by over 100% year-over-year to $2.3 million. Adjusted EBITDA more than doubled to $2.8 million.
-
Reaffirmed Full-Year 2026 Guidance
The company reiterated its full-year 2026 financial guidance, expecting revenue of $66-$68 million and Adjusted EBITDA of $12-$14 million, indicating continued profitability and growth.
-
Significant Operational Momentum
Remaining performance obligations grew 25% year-over-year to $75 million, and a record 117 Deep TMS Systems were shipped, representing a 44% increase compared to the prior year.
-
Pipeline Expansion and Payer Support
BrainsWay secured the first insurer coverage for its accelerated SWIFT™ Deep TMS protocol and plans an FDA filing in Q2 2026 for PTSD symptoms in MDD patients, expanding its clinical pipeline.
Analysis · BWAY · Industrial Applications And Services
BrainsWay delivered robust first-quarter results, significantly exceeding prior-year performance with substantial revenue and net income growth. The company's operational momentum, evidenced by increased system shipments and remaining performance obligations, supports its reaffirmed positive full-year guidance. Strategic investments and an upcoming FDA filing for PTSD further strengthen the long-term growth outlook, indicating continued expansion in its core markets and pipeline.
At the time of this filing, BWAY was trading at $16.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $675.4M. The 52-week trading range was $4.31 to $17.35. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.